NORRIS MEDICINES LTD. Share Price

₹ 14.73

+₹0.70 (4.99%)
1D
Last updated 03 Nov, 2026, 14:18 IST
BSE: 524414
|
Pharmaceuticals

NORRIS MEDICINES LTD. Share Price Today

As of 3 Nov 2026, NORRIS MEDICINES LTD. share price is ₹14.73. The stock opened at ₹13.89, compared to its previous close of ₹14.03. During today's trading session, NORRIS MEDICINES LTD. share price moved in the range of ₹13.89 to ₹14.73, with an average price of ₹14.31 for the day. Looking at its last 52-week, the stock has touched a low of ₹12.00 and a high of ₹20.06.

Share price over the last 1 day rose from 13.89 to 14.73, ranging between 13.89 and 14.73.
₹13.89
4.99% up today
₹14.73
1D LOW
1D HIGH

NORRIS MEDICINES LTD. Stock Insights

Stock Performance
OutperformingBeat Nifty by 4.48 % in last 3 month
NORRIS MEDICINES LTD. stock performance
Open₹13.89
High₹14.73
Low₹13.89
Prev. close₹14.03
NORRIS MEDICINES LTD. trading activity
Volume510
Average traded price₹14.71
Last traded time02:18:40 03 Nov
Last traded quantity500
Circuit
L
H
₹13.33
₹14.73
52-week
L
H
₹12.00
₹20.06
Mkt Cap Cr
14.03
P/E
-37.92
P/B
-0.87
ROA
-2.87%
ROE
1.85%
ROCE
3.44%
Quick Ratio
0.19
EV/EBITDA
69.87

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Norris Medicines has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Norris Medicines appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,24,202.4238.614.759.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7390.3115.7614.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,74,402.4783.099.494.7%11.42%11.37%0.7533.6
Laurus Labs1,26,811.2895.1720.9211.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4826.934.568.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,11,868.0340.542.884.79%7.21%8.58%1.3519.05
Cipla1,11,647.7239.123.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,195.6245.155.817.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.132.566.34%9.25%11.76%1.1512.38
Lupin91,870.1616.454.0714.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

NORRIS MEDICINES LTD. Company Background

ISIN
INE744C01029
Sector Market Cap
₹ 14.03 Cr

Norris Medicines Limited is an India-based company, which is focused on the health care industry. The Company is engaged in the manufacturing and exporting medicines and injections. The Company’s product categories include antibiotic, anti-inflammatory and analgesic range, G. I. range, dermatological range, nutrition range, anti-malaria, anti-emetic, cough/cold range, dental range, diabetics and cardiac, and miscellaneous range. Its antibiotic products include Arizon-100, Arizon-250, Arizon-500, Cefan-dry syurp, and Cefan DT-50. Its G.I. products include Denzym Syrup, Denzym Oral Drop, Ezynor-20, Regus-DSR, Sucrinor and Rinotac. Its dermatological products include Clobec-G, Gabax, Morfit Plus, Novadin-M, Silwon-C and Tioderm. Its nutrition products include Cand XP, Cand Fort, Can D suspension and Hemfit Plus Syrup. It has two plants situated at GIDC, Ankleshwar, Gujarat. Both the plants of the Company are World Health Organization Good Manufacturing Practices (WHO GMP) approved.

NORRIS MEDICINES LTD. Financial Highlights

  • Revenue: NORRIS MEDICINES LTD. reported revenue of ₹8.18 crore in FY26 vs ₹5.88 crore in FY25. It showed an increase of 39.12% on a yearly basis.
  • Operating Profit: NORRIS MEDICINES LTD. reported an operating loss of ₹0.28 crore in FY26 vs ₹1.18 crore in FY25. It showed an increase of 76.27% on a year-on-year basis.
  • Net Profit: NORRIS MEDICINES LTD. reported a net loss of ₹0.28 crore in FY26 vs ₹1.24 crore in FY25. It showed an increase of 77.42% on a yearly basis.

NORRIS MEDICINES LTD. Quarterly Result Highlights

  • NORRIS MEDICINES LTD. reported revenue of ₹0.92 crore in Jun 2026, compared with ₹1.43 crore in Mar 2026, representing a decrease of 35.66% on a quarter-on-quarter (QoQ) basis.
  • NORRIS MEDICINES LTD. reported an operating loss of ₹0.40 crore in Jun 2026, compared with ₹0.05 crore in Mar 2026, representing a decrease of 900.00% on a quarter-on-quarter (QoQ) basis.
  • NORRIS MEDICINES LTD. reported a loss of ₹0.40 crore in Jun 2026, compared with ₹0.05 crore in Mar 2026, reflecting a decrease of 900.00% on a QoQ basis.
  • The earnings per share (EPS) of NORRIS MEDICINES LTD. stood at ₹0.28 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
34.01%
FII
0.00%
Other DII
0.06%
Retail and other
65.92%
Mutual funds
0.01%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Sep 20260.00%

NORRIS MEDICINES LTD. Investment Returns

1 day
-0.64%
1 week
-1.96%
1 month
-13.93%
1 year
-11.20%
3 years
+1.89%
5 years
+1.89%

NORRIS MEDICINES LTD. Share Price History

NORRIS MEDICINES LTD. share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹14.19 / ₹14.03
-0.64%
30 Oct 26
₹14.61 / ₹14.12
-3.42%
28 Oct 26
₹15.00 / ₹14.62
-2.53%
27 Oct 26
₹14.45 / ₹15.00
+4.82%
Show more

NORRIS MEDICINES LTD. Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹8.13₹5.82₹5.64₹8.36
Other Income₹0.05₹0.06₹0.03₹0.01
Total Revenue₹8.18₹5.88₹5.66₹8.37
Total Expenses₹8.46₹7.06₹6.76₹9.57
Profit Before Tax-₹0.28-₹1.18-₹1.10-₹1.19
Tax₹0.00₹0.06₹0.09₹0.56
Profit After Tax-₹0.28-₹1.24-₹1.19-₹1.75
EPS - Basic-₹0.28-₹1.24-₹1.19-₹1.75
EPS - Diluted-₹0.28-₹1.24-₹1.19-₹1.75

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹0.28-₹1.24-₹1.19-₹1.75
Income before WC changes₹0.70-₹0.22-₹0.15₹0.92
Change in Assets₹0.51-₹0.19-₹1.20-₹0.65
Change in Liabilities-₹0.62₹0.92₹1.52₹0.92
Change in WC-₹0.11₹0.73₹0.32₹0.27
Cash flow from Operations₹0.59₹0.51₹0.17₹1.20
Cash flow from Investing-₹0.09₹0.00₹0.05-₹0.02
Cash flow from Financing-₹0.52-₹0.50-₹0.20-₹1.18
Total Cash Flow-₹0.02₹0.00₹0.02₹0.00
Cash (Start of the year)₹0.04₹0.04₹0.02₹0.02
Cash (End of the year)₹0.02₹0.04₹0.04₹0.02

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹7.08₹7.47₹8.04₹8.77
Current Assets₹5.81₹6.34₹6.14₹4.92
Total Assets₹12.89₹13.81₹14.19₹13.69
Current Liabilities₹9.53₹10.15₹9.23₹7.70
Net Current Asset-₹3.71-₹3.81-₹3.08-₹2.78
Non-Current Liabilities₹18.51₹18.53₹18.59₹18.43
Equity Capital-₹15.15-₹14.87-₹13.63-₹12.44
Total Equity & Liabilities₹12.89₹13.81₹14.19₹13.69
* All values are in INR Crore
NORRIS MEDICINES LTD. market depth
Bid quantityBid priceAsk priceAsk quantity
0000
0000
0000
0000
0000
Total bid quantity0
Total ask quantity0
NORRIS MEDICINES LTD. technical summary
Bearish indicators2
Neutral indicators3
Bullish indicators3
OverallSlightly Bullish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
37.18
Neutral
ATR (14)
0.9
Neutral
STOCH(9,6)
0.48
Bullish
STOCH RSI (14)
3.56
Bullish
ADX(9)
28.9
Bearish
UO(9)
32.67
Neutral
ROC(12)
-6.47
Bearish
WillR(14)
-99.61
Bullish
Period
Simple value
Exponential vaue
5D
14.42
14.41
10D
14.86
14.78
20D
15.36
15.32
50D
15.91
15.68
100D
15.51
15.42
Volume trend — traded volume by day
3 Nov0L
2 Nov0L
30 Oct0L
28 Oct0L
27 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

NORRIS MEDICINES LTD.
Pharmaceuticals
Add Stock
Add Another

NORRIS MEDICINES LTD. Returns Calculator

Top Gainers

KRBL Share Price
₹401.45
+38.45 (+10.59%)
MARICO Share Price
₹878.40
+79.85 (+10%)
BALRAMCHIN Share Price
₹654.80
+54.9 (+9.15%)
TRIDENT Share Price
₹23.79
+1.58 (+7.11%)
AEGISLOG Share Price
₹1177.10
+77 (+7%)
See more

Top Losers

KEC Share Price
₹316.35
-32.65 (-9.36%)
GNFC Share Price
₹465.05
-45.95 (-8.99%)
PRAJIND Share Price
₹254.63
-16.5 (-6.09%)
AIAENG Share Price
₹3389.70
-217.6 (-6.03%)
GESHIP Share Price
₹1536.50
-63.9 (-3.99%)
See more

NORRIS MEDICINES LTD. Share Price FAQs

Please be aware that NORRIS MEDICINES LTD. stock prices are subject to continuous fluctuations due to various factors.